Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis.

Bibliographic Details
Title: Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis.
Authors: Bozek A; Clinical Department of Internal Diseases, Dermatology and Allergology in Zabrze, Medical University of Silesia, Katowice, Poland., Kozłowska R; Clinical Department of Internal Diseases, Dermatology and Allergology in Zabrze, Medical University of Silesia, Katowice, Poland., Misiołek M; Department of Otorhinolaryngology and Laryngological Oncology in Zabrze, Medical University of Silesia, Katowice, Poland., Ścierski W; Department of Otorhinolaryngology and Laryngological Oncology in Zabrze, Medical University of Silesia, Katowice, Poland., Gawlik R; Clinical Department of Internal Diseases, Allergology and Clinical Immunology in Zabrze, Medical University of Silesia, Katowice, Poland.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Nov 30; Vol. 18 (6), pp. 2097818. Date of Electronic Publication: 2022 Jul 11.
Publication Type: Journal Article
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Complete
Full text is not displayed to guests.
Description
ISSN:2164-554X
DOI:10.1080/21645515.2022.2097818